| Mitchell Alan Harris, MD | |
|
13100 E 136th St Ste 1200, Fishers, IN 46037-9418 | |
| (317) 678-3100 | |
| Not Available |
| Full Name | Mitchell Alan Harris |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 13100 E 136th St Ste 1200, Fishers, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285741942 | NPI | - | NPPES |
| 100132010 | Medicaid | IN | |
| 000000086775 | Other | IN | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 01037994A (Indiana) | Primary |
| Entity Name | Eskenazi Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730451063 PECOS PAC ID: 4284546813 Enrollment ID: O20031103000440 |
News Archive
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
A study published in the August 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports on a group of boys diagnosed with ADHD in childhood and followed into adulthood.
Around a quarter of young people at high risk for mood disorders have a substance use disorder, results from a Canadian study suggest.
Washington Research Foundation is helping University of Washington clinicians and researchers —one a MacArthur Fellow — to develop BiliCam, an iPhone app that can help determine the severity of jaundice in a newborn without having to draw blood.
Boston Children's Hospital has been awarded two five-year grants by the National Institutes of Health to co-lead the HEALthy Brain and Child Development (HBCD) study, an ambitious, comprehensive national study of brain development from birth through early childhood.
› Verified 3 days ago
| Entity Name | University Pediatric Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457396541 PECOS PAC ID: 2163326794 Enrollment ID: O20031125000021 |
News Archive
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
A study published in the August 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports on a group of boys diagnosed with ADHD in childhood and followed into adulthood.
Around a quarter of young people at high risk for mood disorders have a substance use disorder, results from a Canadian study suggest.
Washington Research Foundation is helping University of Washington clinicians and researchers —one a MacArthur Fellow — to develop BiliCam, an iPhone app that can help determine the severity of jaundice in a newborn without having to draw blood.
Boston Children's Hospital has been awarded two five-year grants by the National Institutes of Health to co-lead the HEALthy Brain and Child Development (HBCD) study, an ambitious, comprehensive national study of brain development from birth through early childhood.
› Verified 3 days ago
| Entity Name | University Family Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043275787 PECOS PAC ID: 7911992797 Enrollment ID: O20040420000393 |
News Archive
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
A study published in the August 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports on a group of boys diagnosed with ADHD in childhood and followed into adulthood.
Around a quarter of young people at high risk for mood disorders have a substance use disorder, results from a Canadian study suggest.
Washington Research Foundation is helping University of Washington clinicians and researchers —one a MacArthur Fellow — to develop BiliCam, an iPhone app that can help determine the severity of jaundice in a newborn without having to draw blood.
Boston Children's Hospital has been awarded two five-year grants by the National Institutes of Health to co-lead the HEALthy Brain and Child Development (HBCD) study, an ambitious, comprehensive national study of brain development from birth through early childhood.
› Verified 3 days ago
| Entity Name | Indiana University Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902032832 PECOS PAC ID: 5799755864 Enrollment ID: O20040727000955 |
News Archive
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
A study published in the August 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports on a group of boys diagnosed with ADHD in childhood and followed into adulthood.
Around a quarter of young people at high risk for mood disorders have a substance use disorder, results from a Canadian study suggest.
Washington Research Foundation is helping University of Washington clinicians and researchers —one a MacArthur Fellow — to develop BiliCam, an iPhone app that can help determine the severity of jaundice in a newborn without having to draw blood.
Boston Children's Hospital has been awarded two five-year grants by the National Institutes of Health to co-lead the HEALthy Brain and Child Development (HBCD) study, an ambitious, comprehensive national study of brain development from birth through early childhood.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mitchell Alan Harris, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Mitchell Alan Harris, MD 13100 E 136th St Ste 1200, Fishers, IN 46037-9418 Ph: (317) 678-3100 |
News Archive
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
A study published in the August 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports on a group of boys diagnosed with ADHD in childhood and followed into adulthood.
Around a quarter of young people at high risk for mood disorders have a substance use disorder, results from a Canadian study suggest.
Washington Research Foundation is helping University of Washington clinicians and researchers —one a MacArthur Fellow — to develop BiliCam, an iPhone app that can help determine the severity of jaundice in a newborn without having to draw blood.
Boston Children's Hospital has been awarded two five-year grants by the National Institutes of Health to co-lead the HEALthy Brain and Child Development (HBCD) study, an ambitious, comprehensive national study of brain development from birth through early childhood.
› Verified 3 days ago
Aaron Gunnar Shoemaker, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 7199 Easy St, Fishers, IN 46038 Phone: 317-415-6110 | |
Theresa C Treep, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10017 Water Crest Drive, Fishers, IN 46038 Phone: 317-776-9214 Fax: 317-776-9219 | |
Heather E Slaven, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9795 E 116th St, Fishers, IN 46037 Phone: 317-913-8100 | |
Dr. Sean C Keller, Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13100 E 136th St, Ste 1200, Fishers, IN 46037 Phone: 317-678-3100 Fax: 317-678-3108 | |
Anthony Joseph Damore, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 13121 Olio Rd Ste 260, Fishers, IN 46037 Phone: 317-621-7337 | |
Quinn Danielle Bensi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 13121 Olio Rd Ste 340, Fishers, IN 46037 Phone: 317-621-7337 Fax: 317-621-7330 |